Carteolol Hydrochloride

Spécifications

51781-21-6Numéro CAS

257-415-7Numéro CE

5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochlorideNom IUPAC

C16H25ClN2O3Formule chimique

328.83 g/molMasse molaire

carteolol hydrochloride; 51781-21-6; Carteolol HCl; Cartrol; Ocupress; Abbott-43326; OPC-1085; Teoptic; DTXSID4045478; NSC-300906; 4797W6I0T4; DTXCID2025478; 5-(2-Hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyril hydrochloride; 5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydrocarbostyril monohydrochloride; NSC300906; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2(1H)-quinolinone hydrochloride; 5-(3-tert-Butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1H)-chinolinon-hydrochlorid; 5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone Hydrochloride; CHEBI:3438; 5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril monohydrochloride; Hydrochloride, Carteolol; RefChem:58564; Carteolol Monohydrochloride; Monohydrochloride, Carteolol; OPC1085; 5-((2RS)-3-(1,1-Dimethylethyl)amino-2-hydroxypropyloxy)-3,4-dihydroquinolin-2(1H)-one monohydrochloride; Arteoptic; Mikelan; Endak; Endak hydrochloride; Carteol; dl-Carteolol Hydrochloride; OPC 1085; NSC 300906; Carteolol (hydrochloride); OPC-1085 hydrochloride; MFCD00941499; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochloride; 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1); Carbonolol; Endak mite; Abbott 43326; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydroquinolin-2-one hydrochloride; EINECS 257-415-7; Arteolol; Caltidren; Optipress; Tenalet; (+/-)-Carteolol Hydrochloride; UNII-4797W6I0T4; Mikelan LA; Ocupress (TN); 5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone Hydrochloride; (+/-)-Carteolol Hydrochloride; dl-Carteolol Hydrochloride;; Cartrol (TN); Carteolol hydrochloride [USAN:USP:JAN]; NCGC00016865-01; 5-(3-tert-Butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride; dl-Carte olol hydrochloride; CAS-51781-21-6; 5-(3-tert-Butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1H)-chinolinon-hydrochlorid [German]; SCHEMBL41380; MLS002153816; orb1224839; orb1309135; CHEMBL1201002; SCHEMBL29506901; MSK10971A; FYBXRCFPOTXTJF-UHFFFAOYSA-N; Carteolol hydrochloride (Standard); HMS1569I14; HMS5083C03; HY-17495AR; Pharmakon1600-01505519; EX-A1257; CARTEOLOL HYDROCHLORIDE [MI]; Tox21_110654; Carteolol for system suitability CRS; Carteolol hydrochloride (JP18/USP); CARTEOLOL HYDROCHLORIDE [JAN]; HY-17495A; NSC760060; s4278; CARTEOLOL HYDROCHLORIDE [USAN]; AKOS027379166; Carteolol hydrochloride [EP monograph]; Tox21_110654_1; CARTEOLOL HYDROCHLORIDE [MART.]; CARTEOLOL HYDROCHLORIDE [VANDF]; CCG-213475; FC19826; NSC-760060; OC 1085; 5-(3-((tert-Butyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2-quinolone monohydrochloride; CARTEOLOL HYDROCHLORIDE [USP-RS]; CARTEOLOL HYDROCHLORIDE [WHO-DD]; NCGC00179541-03; 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, monohydrochloride; AS-74897; SMR001233186; DB-052022; C3015; CARTEOLOL HYDROCHLORIDE [ORANGE BOOK]; NS00089033; SW197155-3; CARTEOLOL HYDROCHLORIDE [USP IMPURITY]; C75429; CARTEOLOL HYDROCHLORIDE [USP MONOGRAPH]; D00599; WLN: T66 BMVT&J GO1YQ1MX1&1&1 &GH; SR-01000841202; SR-01000841202-2; Q27106078; 5-(3-t-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride; 2(1H)-Quinolinone,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, monohydrochloride; 5-[3-(tert-butylamino)-2-hydroxy-propoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochloride; 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-,hydrochloride (1:1); 5-[(2RS)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]- 3,4-dihydroquinolin-2(1H)-one hydrochloride; 5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one--hydrogen chloride (1/1)Synonymes